Tag Archives: Nordisk039s

Novo Nordisk's Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study – Reuters

Novo Nordisk’s Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study  Reuters Weight loss drugs can halve heart patients’ risk of early death, study finds  The Guardian Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease  PR Newswire Weight loss jabs could …

Read More »

Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH – Reuters

Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH  Reuters Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis  PR Newswire Novo Nordisk’s obesity drug Wegovy cleared to treat MASH  statnews.com Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH  Yahoo Finance Novo Nordisk’s Wegovy Gets US Approval for …

Read More »